Advertisement
KIDS vs XRAY
Which Stock Would AI Choose? OrthoPediatrics (KIDS) vs. DENTSPLY Sirona (XRAY) Stock Comparison
Key Takeaways
- OrthoPediatrics (KIDS) is a pediatric orthopedic device specialist posting double-digit revenue growth and rising guidance, while DENTSPLY Sirona (XRAY) is a global dental equipment and consumables maker working through a turnaround marked by softer growth and leadership transitions.
- Tickeron AI Verdict: KIDS. Trend consistency, stronger relative momentum, and an improving profitability and cash-flow trajectory currently favor OrthoPediatrics over DENTSPLY Sirona in this head-to-head stock comparison.
- KIDS recently raised its full-year revenue outlook and moved toward free-cash-flow break-even, whereas XRAY's market positioning reflects reduced guidance and tempered analyst expectations.
- Sentiment diverges sharply: sell-side consensus on KIDS skews "Buy," while XRAY carries a "Hold" consensus amid a multi-month share-price slide.
- For more context on each name, explore KIDS Major News and KIDS Today's Price Move, along with XRAY Major News and XRAY Today's Price Move.
- Explore Trending AI Robots to see which automated trading strategies are currently favored by Tickeron's AI.
Introduction
Both KIDS and XRAY operate in the healthcare and medical-technology space, yet they sit at very different stages of their growth and profitability cycles. OrthoPediatrics is a focused pediatric orthopedics pure-play benefiting from durable procedure demand and a pipeline of new product launches, while DENTSPLY Sirona is a much larger dental equipment and consumables leader navigating restructuring, distribution realignment, and leadership change. This comparison is most relevant to investors and traders evaluating relative performance and market positioning between a high-growth specialty-device story and a value-oriented turnaround. Understanding the contrast in momentum, catalysts, and risk can help clarify which name offers the more favorable setup in the current market environment.
KIDS Overview and Recent Performance
KIDS, or OrthoPediatrics Corp., designs and sells anatomically appropriate implants, instruments, and specialty bracing exclusively for children with orthopedic conditions. Because the procedures it supports are generally non-elective, demand tends to be more stable than in consumer-discretionary healthcare categories. Recent market activity has rewarded this positioning: the stock has gained roughly 18% over the past three months and approximately 41% over the trailing year, climbing toward the upper end of its 52-week range.
The catalyst behind this strength has been fundamentals. In its most recent quarter, OrthoPediatrics reported revenue of about $72.7 million, up 19% year over year, and raised its full-year revenue guidance to a range of $270 million to $273 million, implying 14% to 16% growth. Management highlighted strong procedure volumes, record adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization), and a move to positive free cash flow. A multi-year "product launch super cycle" in trauma, deformity, and scoliosis remains in its early stages, giving analysts a basis for their broadly positive, "Buy"-leaning ratings and recently raised price targets.
XRAY Overview and Recent Performance
XRAY, or DENTSPLY Sirona Inc., is among the world's largest manufacturers of professional dental equipment, consumables, and digital dentistry technology. In contrast to KIDS, the company is navigating a reset: recent quarters have featured softer earnings, reduced guidance, and ongoing leadership turnover, while a multi-year revenue trend has been broadly flat to slightly down. The stock has pulled back sharply in recent weeks, with a roughly 20% to 25% decline over the trailing 30 days and a one-year total return that remains negative.
Offsetting some of this pressure, management has been actively broadening its distribution footprint, including an expanded relationship with Midwest Dental that extends a historically consumables-focused partnership into the company's full digital-technology portfolio. The company also pays a quarterly dividend, which can appeal to income-oriented investors. Nevertheless, analysts have trimmed price targets and generally maintain a "Hold" consensus, reflecting caution around the timing of any margin and growth recovery. The shares trade near the low end of their 52-week range, signaling persistent investor skepticism about the pace of the turnaround.
Trending AI Robots
Tickeron operates hundreds of AI trading bots that collectively trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance record, and universe of symbols. Because not every bot suits every market condition, Tickeron curates the most relevant strategies into a dedicated Trending AI Robots page. This section highlights only the bots currently best aligned with prevailing market dynamics, helping traders cut through the noise and focus on actionable, data-driven signals rather than subjective calls. Whether you follow short-term momentum, swing patterns, or longer-horizon trends, exploring the curated list can offer a clearer view of where automated, rules-based analysis is currently concentrating. Review the Trending AI Robots page to see which strategies are leading right now.
Head-to-Head Comparison
The most striking contrast between these two names is trajectory. KIDS is in a growth-and-inflection phase: revenue is expanding at a mid-to-high-teens rate, profitability metrics are improving, and free cash flow has turned positive. Its risk profile centers on execution—delivering on the product-launch "super cycle" and converting top-line growth into sustained profitability while managing a still-negative GAAP (Generally Accepted Accounting Principles) bottom line.
XRAY, by comparison, offers scale, an established global franchise, and a dividend, but carries a more challenged growth profile. Its trade-offs involve a turnaround dependent on cost discipline, distribution resets, and regaining share in a fragmented, increasingly competitive digital-dentistry market. Sector exposure also differs: KIDS concentrates in pediatric orthopedics with limited direct competition, while XRAY spans a broader, more competitive dental ecosystem subject to elective-procedure sensitivity and tariff-related cost pressures. In terms of market sentiment, the gap is wide—one stock is seeing raised targets and buy-side enthusiasm, while the other is absorbing downgrades and price-target reductions.
Tickeron AI Verdict
Based on observable trend data, relative momentum, and fundamental positioning, Tickeron's AI currently favors KIDS over XRAY. OrthoPediatrics presents the more consistent trend structure: rising revenue, improved adjusted EBITDA, positive free cash flow, and upward guidance revisions, all of which align with the stock's recent relative strength. DENTSPLY Sirona, while arguably carrying a more discounted valuation and a dividend, has yet to demonstrate the durable catalysts needed to reverse its downtrend. Probabilistically, the weight of observable evidence—momentum, stability, and near-term catalysts—leans toward KIDS, though this assessment reflects current conditions rather than a guarantee of future performance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KIDS is a Hold and XRAY is a Hold.
KIDS's RSI Indicator is remaining in overbought zone for 9 days
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KIDS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
KIDS broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on KIDS as a result. In 63 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for KIDS just turned positive on October 20, 2026. Looking at past instances where KIDS's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.
KIDS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for KIDS crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +10.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where KIDS advanced for three days, in 216 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 80 of 130 cases where KIDS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.413) is normal, around the industry mean (4.142). P/E Ratio (-18.905) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.175) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. KIDS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KIDS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
XRAY in upward trend: price rose above 50-day moving average on November 10, 2026
XRAY moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend. In 28 of 35 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on XRAY as a result. In 55 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for XRAY just turned positive on October 09, 2026. Looking at past instances where XRAY's MACD turned positive, the stock continued to rise in 30 of 53 cases over the following month. The odds of a continued upward trend are 57%.
The 10-day moving average for XRAY crossed bullishly above the 50-day moving average on November 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 45%.
Following a +2.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where XRAY advanced for three days, in 174 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
Bearish Trend Analysis
The 10-day RSI Indicator for XRAY moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 22 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 63 cases where XRAY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XRAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
XRAY broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for XRAY entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.396) is normal, around the industry mean (4.964). P/E Ratio (-3.465) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.601) is also within normal values, averaging (4.143). XRAY's Dividend Yield (0.068) is considerably higher than the industry average of (0.005). P/S Ratio (0.557) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. XRAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XRAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
KIDS | XRAY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 90 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 97 | |
PRICE GROWTH RATING 1..100 | 34 | 58 | |
P/E GROWTH RATING 1..100 | 94 | 15 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
XRAY's Valuation (6) in the Medical Specialties industry is in the same range as KIDS (14). This means that XRAY’s stock grew similarly to KIDS’s over the last 12 months.
XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as KIDS (100). This means that XRAY’s stock grew similarly to KIDS’s over the last 12 months.
KIDS's SMR Rating (94) in the Medical Specialties industry is in the same range as XRAY (97). This means that KIDS’s stock grew similarly to XRAY’s over the last 12 months.
KIDS's Price Growth Rating (34) in the Medical Specialties industry is in the same range as XRAY (58). This means that KIDS’s stock grew similarly to XRAY’s over the last 12 months.
XRAY's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for KIDS (94). This means that XRAY’s stock grew significantly faster than KIDS’s over the last 12 months.
| KIDS | XRAY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 60% |
| MACD ODDS (%) | 2 days ago 70% | 2 days ago 57% |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 74% |
| TrendMonth ODDS (%) | 2 days ago 69% | 2 days ago 63% |
| Advances ODDS (%) | 8 days ago 76% | 2 days ago 60% |
| Declines ODDS (%) | 6 days ago 82% | 6 days ago 73% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 75% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KIDS’s FA Score shows that 1 FA rating(s) are green while XRAY’s FA Score has 2 green FA rating(s).
- KIDS’s FA Score: 1 green, 4 red.
- XRAY’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KIDS’s TA Score shows that 6 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).
- KIDS’s TA Score: 6 bullish, 4 bearish.
- XRAY’s TA Score: 5 bullish, 5 bearish.
Price Growth
KIDS (@Medical/Nursing Services) experienced а +6.59% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -0.31% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.
Reported Earning Dates
KIDS is expected to report earnings on Mar 10, 2027.
XRAY is expected to report earnings on Mar 04, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+1.96% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
KIDS and
Correlation & Price change
A.I.dvisor indicates that over the last year, KIDS has been loosely correlated with CNMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KIDS jumps, then CNMD could also see price increases.
| Ticker / NAME | Correlation To KIDS | 1D Price Change % | ||
|---|---|---|---|---|
| KIDS | 100% | -1.50% | ||
| CNMD - KIDS | 50% Loosely correlated | -1.41% | ||
| XRAY - KIDS | 48% Loosely correlated | +1.68% | ||
| OFIX - KIDS | 45% Loosely correlated | -9.87% | ||
| GEHC - KIDS | 44% Loosely correlated | -0.45% | ||
| MDT - KIDS | 42% Loosely correlated | -1.17% | ||
More | ||||
XRAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To XRAY | 1D Price Change % | ||
|---|---|---|---|---|
| XRAY | 100% | +1.68% | ||
| NVST - XRAY | 62% Loosely correlated | -0.50% | ||
| ALGN - XRAY | 59% Loosely correlated | N/A | ||
| QDEL - XRAY | 50% Loosely correlated | -4.71% | ||
| KIDS - XRAY | 48% Loosely correlated | -1.50% | ||
| STE - XRAY | 46% Loosely correlated | +0.07% | ||
More | ||||